Clinical Trial

Sensitivity of Repetitive Nerve Stimulation Performed in the Evening vs in the Morning in Myasthenia Gravis

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated October 10, 2024 (before its estimated May 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
Myasthenia gravis (MG) is the autoimmune disorder affecting the neuromuscular junction, characterized by fatigue, which increases gradually through the day. The repetitive nerve stimulation (RNS) remains the key diagnostic test in MG, however its sensitivity, especially in ocular form of MG is not satisfactory. In this study, investigators want to assess the impact of the time of the day on the sensitivity of the RNS. We hypothesize the RNS performed in the evening may be more sensitive than in the morning.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2022-04-13; most recent amendment 2024-10-09.
Status change: Not Yet Recruiting → Recruiting 2022-04-25
Trial Details
NCT Number NCT05337891
Lead Sponsor Jagiellonian University
Conditions Myasthenia Gravis
Enrollment 40 participants
Start Date 2022-06-03
Primary Completion 2026-05-01 (estimated)
Study Completion 2026-09-01 (estimated)
Updated on ClinicalTrials.gov 2024-10-10